Investors need to pay close attention to Aimmune (AIMT) stock based on the movements in the options market lately. Yahoo Finance · Feb 21 · Startup gobbles up Real time Aimmune Therapeutics (AIMT) stock price quote, stock graph, news & analysis. Stock quote and company snapshot for AIMMUNE THERAPEUTICS INC (AIMT), including profile, stock chart, recent news and events, analyst opinions, and In depth view into AIMT (Aimmune Therapeutics) stock including the latest Independent Director Patrick Enright Just Bought Shares In Aimmune Therapeutics, Inc. (NASDAQ:AIMT). 03/22 08:06. Yahoo Cash from Financing ( TTM) 55.88M Should you invest in Aimmune Therapeutics (NasdaqGS:AIMT)? Mediocre balance sheet Financial Health. How is Aimmune Therapeutics's financial position?
Aimmune Therapeutics Inc (AIMT) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics.
Aimmune Therapeutics, Inc. (AIMT): Price and Financial Metrics. AIMT Home · AIMT News · AIMT Ratings · AIMT Charts · AIMT Social. $14.08 0.72 (5.39%) View today's stock price, news and analysis for Aimmune Therapeutics Inc. (AIMT ). Barron's also provides information on historical stock ratings, target prices, company earnings, Eric Hands Claude Bjerkholt MBAChief Financial Officer. 13 Mar 2020 (NASDAQ:AIMT) marked $17.57 per share versus a previous $19.37 closing price. With having a -9.29% loss, an insight into the fundamental Aimmune Therapeutics Stock Price Forecast, AIMT stock price prediction. Wall Street Stock Market & Finance report, prediction for the future: You'll find the 26 Feb 2020 View detailed financial information, real-time news, videos, quotes and analysis on Aimmune Therapeutics Inc. (NASDAQ:AIMT). Explore Live AIMMUNE THERAPEUTICS (AIMT) stock price, quote, history, news and charts. Find out how to buy AIMMUNE THERAPEUTICS stocks with our Latest Aimmune Therapeutics Inc (AIMT:NSQ) share price with interactive charts 2019 Financial Results and Recent Operational Highlights February 20, 2020
Historical daily share price chart and data for Aimmune Therapeutics since 2020 adjusted for splits. The latest closing stock price for Aimmune Therapeutics as
AIMMUNE AIMT Stock Surges In After-hours On FDA Approval February 1, 2020 by Lance Jepsen AIMT stock surged 16% in after-hours trading on January 31, 2020, after the … Earnings Whisper Number for AIMT: Aimmune Therap Aimmune Therap (AIMT) reports earnings on 5/28/2020. Shares are down 37.2% since reporting last quarter. The Earnings Whisper Score gives the statistical odds for the stock ahead of earnings. AIMT 13F Hedge Fund and Asset Management Owners Bill.com 13F holdings: Abdiel, Dragoneer, Tiger Global and other top funds bought the stock's IPO in Q4. They're up 180% in 2 months. via whalewisdomalpha 02/20/2020; Here’s Whose Been Buying Tesla’s Stock During Its Massive Run-up 02/18/2020 Scion's Q4 2019 13F released. Aimmune Stock Halted as FDA Considers Peanut Allergy ...
102 rows · Discover historical prices for AIMT stock on Yahoo Finance. View daily, weekly or monthly …
Detailed price information for Aimmune Therap (AIMT-Q) from The Globe and Mail including Market movers: Stocks that saw action on Wednesday - and why . Aimmune Therapeutics, Inc. (AIMT) Stock ... - Yahoo Finance Find the latest Aimmune Therapeutics, Inc. (AIMT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Should I buy Aimmune Therapeutics, Inc. (AIMT)? Use the Zacks Rank and Style Scores to find out is AIMT is right for your portfolio.
Aimmune Therapeutics, Inc. Common Stock (AIMT) Pre-Market ... Aimmune Therapeutics, Inc. Common Stock (AIMT) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.